Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common stock, $0.00001 par value per share
-
Shares outstanding
-
60,389,334
-
Total 13F shares
-
59,105,909
-
Share change
-
+8,080,921
-
Total reported value
-
$2,908,525,208
-
Put/Call ratio
-
119%
-
Price per share
-
$49.38
-
Number of holders
-
191
-
Value change
-
+$350,228,550
-
Number of buys
-
115
-
Number of sells
-
86
Institutional Holders of Twist Bioscience Corp - Common stock, $0.00001 par value per share (TWST) as of Q1 2022
As of 31 Mar 2022,
Twist Bioscience Corp - Common stock, $0.00001 par value per share (TWST) was held by
191 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
59,105,909 shares.
The largest 10 holders included
FMR LLC, ARK Investment Management LLC, Capital World Investors, VANGUARD GROUP INC, BlackRock Inc., Jackson Square Partners, LLC, STATE STREET CORP, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc., and JPMORGAN CHASE & CO.
This page lists
194
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.